Examples of using RVC urges in English and their translations into Russian
{-}
-
Official
-
Colloquial
The RVC urges genotyping of≥80% of rubella chains of transmission.
Specific comments to country The RVC urges consideration is given to improvement of quality of information on surveillance performance and population immunity.
RVC urges that implementation of the new National Vaccine Plan begin as soon as possible.
Specific comments to country The RVC urges activities to reach and maintain≥95% coverage with both doses of MRCV in routine immunization and at all administrative levels.
The RVC urges the national health authorities to improve the rate of viral detection of rubella.
The RVC urges efforts to increase vaccination coverage and close existing immunity gaps.
The RVC urges for activities in response to the outbreak, and is anticipating a detailed ASU for 2018.
The RVC urges Monaco to establish an NVC and to submit an ASU 2013 to the WHO Secretariat as soon as possible.
The RVC urges establishment of an integrated mechanism for calculation of the national immunization coverage.
The RVC urges the national health authorities to maintain immunization coverage of≥95% with both doses of MRCV.
The RVC urges further improvement in the epidemiological surveillance of measles and rubella with better contact tracing.
The RVC urges improvement of the quality of measles and rubella surveillance including the rate of viral detection for rubella.
The RVC urges further measures to reverse the decline in MRCV coverage at national and subnational levels.
The RVC urges increasing of population immunity by further improving MRCV1 vaccination coverage and addressing known immunity gaps.
RVC urges the national health authorities to consider additional activities to improve the MRCV coverage in the country.
The RVC urges the national health authorities to consider additional activities to further increase MRCV2 coverage.
However, the RVC urges improvement of the quality of measles and rubella surveillance and increasing of MRCV2 at subnational(cantonal) level.
The RVC urges the national health authorities to take additional steps to address these issues in line with WHO recommendations.
The RVC urges further steps to be taken to achieve and maintain high vaccination coverage with 2 doses of MRCV at all administrative levels.
The RVC urges the NVCs of Italy, Serbia, the former Yugoslav Republic of Macedonia and Ukraine to submit all missing documentation as soon as possible.
The RVC urges the national health authorities to maintain high-quality surveillance and take appropriate measures to ensure high MRCV coverage.
The RVC urges strengthening of CRS surveillance and establishment of a comprehensive nationwide system, to ensure confidence in the rubella elimination status.
The RVC urges health authorities for additional activities to improve the quality of routine immunization and surveillance, particularly at the sub-national level.
The RVC urges national health authorities to undertake necessary measures to improve the surveillance performance and address the declining vaccination coverage.
The RVC urges that the quality of rubella surveillance be further improved and strengthened nationwide, including genotyping of≥80% of rubella chains of transmission.
The RVC urges further steps be taken to achieve and maintain high vaccination coverage with 2 doses of MRCV at all administrative levels and among all susceptibles.
The RVC urges the national health authorities to improve the rate of viral detection of rubella and to take adequate measures to further improve both MRCV1 and MRCV2 coverage.
The RVC urges improvement in the rate of viral detection of measles and rubella through the submission of specimens to a WHO-accredited regional reference laboratory for genotyping.
The RVC urges national health authorities to consider comprehensive response to the measles outbreak, followed with SIA to close the population immunity gaps nationwide.
The RVC urges the national health authorities to consider further efforts to improve surveillance performance and maintain immunization coverage of≥95% with both doses of MRCV at national and subnational levels.
